SCHEMBL2136799

SCHEMBL2136799

CCC1(CC)C(=O)N(C(C)(C)C)CC(C)(C)N1OC(C)c1ccc(C(=O)N2CCN(C)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 4/20 0.37
NPC1 O15118 1/20 0.36
EPHX2 P34913 1/20 0.35
HRH3 Q9Y5N1 2/20 0.35
F2 P00734 1/20 0.35
ELANE P08246 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CHKA P35790 1/20 0.34
NAMPT P43490 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12738654 0.90 ALDH1A1 (0.35) HPGDKMT2AALDH1A1MEN1SMN1; SMN2
Iodide SCHEMBL2136222 0.89 ALDH1A1 (0.35) KMT2AALDH1A1MEN1SMN1; SMN2LMNA
SCHEMBL2141054 0.86 RXRA (0.32)
SCHEMBL6884754 0.80 ELANE (0.30) ELANE
SCHEMBL12738651 0.76
Hydrochloric Acid SCHEMBL2137332 0.76
SCHEMBL7070810 0.71
SCHEMBL7071716 0.71
SCHEMBL7644926 0.68 L3MBTL1 (0.37) KMT2AALDH1A1MEN1SMN1; SMN2
SCHEMBL7071196 0.68 ELANE (0.32) ALDH1A1ELANECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902368-B2 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines BASF SE (DE) 2011-03-08 US disclosed
US-20090306382-A1 CATIONIC ALKOXYAMINES MUEHLEBACH ANDREAS 2009-12-10 US disclosed
EP-1515950-B1 CATIONIC ALKOXYAMINES AND THEIR USE IN PRODUCING NANO PARTICLES FROM NATURAL OR SYNTHETIC CLAYS BASF SE (DE) 2009-12-02 EP disclosed
US-7595359-B2 Organoclays; coatings, sealants, caulks, adhesives and plastic additives CIBA SPECIALTY CHEMICALS CORPORATION (US) 2009-09-29 US disclosed
US-20050215691-A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays BASF SE (DE) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306382-A1 CATIONIC ALKOXYAMINES ALKBH2, ALKBH3, ALKBH5 HPGD 4092/4885ALOX15 1193/4885KMT2A 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.